Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of PrCABTREOTM (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel) Treatment for Acne Vulgaris
LAVAL, QC – Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance… Read More




